Form 4: Climb Bio CFO Granted 600,000 Stock Options

Climb Bio, Inc.'s Chief Financial Officer, Susan Altschuller, was granted 600,000 stock options with an exercise price of $1.97, vesting over four years.

Summary

• Susan Altschuller, Chief Financial Officer of Climb Bio, Inc. (CLYM), was granted 600,000 stock options.
• The options have an exercise price of $1.97 per share.
• The grant date for these options was October 1, 2025.
• The vesting schedule dictates that 25% of the shares vest on October 1, 2026 (the first anniversary of the grant date).
• The remaining shares are scheduled to vest in 36 equal monthly installments through October 1, 2029.
• Vesting is contingent upon the Reporting Person's continued service to the company.
• The stock options are set to expire on September 30, 2035.

Sentiment

Score: 6

Explanation: The grant of stock options to a key executive is generally a neutral to slightly positive event, as it aligns management incentives with shareholder interests, but does not directly reflect operational performance or financial results.

Positives

• The grant of 600,000 stock options to the Chief Financial Officer aligns management's interests with shareholder value creation.
• The structured vesting schedule encourages long-term retention and sustained performance from a key executive.

Risks

• The vesting of the stock options is subject to the Chief Financial Officer's continued service, meaning the options could be forfeited if employment ceases before full vesting.

Future Outlook

This grant of stock options is a standard component of executive compensation, designed to incentivize the Chief Financial Officer to contribute to the company's long-term growth and shareholder value appreciation, aligning future performance with personal financial incentives.

Industry Context

The granting of stock options to key executives like the Chief Financial Officer is a common practice across various industries, particularly in growth-oriented companies, to attract, retain, and motivate talent by linking their compensation directly to the company's stock performance.

Stakeholder Impact

• Shareholders: The grant aims to align the CFO's financial interests with shareholder value creation, potentially leading to better long-term performance.
• Employees: This compensation structure can serve as a model for other key employees, potentially boosting morale and retention.

Next Steps

• The stock options will vest according to the specified schedule, contingent on the CFO's continued service.
• The CFO may choose to exercise vested options at or before the expiration date.

Key Dates

Keywords

Climb Bio, CLYM, Stock Options, Susan Altschuller, CFO, Equity Compensation, Insider Transaction, Form 4, Vesting